Global Prostate-specific Antigen (PSA) Testing Market Insights, Forecast to 2028

  • Report ID:235931
  • Industry Name: Medical Care
  • Publishing Date: Jun-22
  • No. of Pages: 117

Free Sample

Request Customization

Request A Callback

Enquiry before buying

 
                              

                               
Prostate-specific Antigen (PSA) Testing market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Prostate-specific Antigen (PSA) Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
    CLIA Method
    ELISA Method
Segment by Application
    Screening
    Post-treatment Monitoring
    Other
By Company
    Abbott
    Boston Scientific Corporation
    Bayer AG
    Siemens Healthcare
    DiaSorin
    Roche
    Beckman Coulter
    PerkinElmer
    Tosoh
    Ortho Clinical
    Fujirebio
    Mediwatch
    BodiTech
    Bristol-Myers Squibb Company
    GE Healthcare
    Endocare
    Merck?Co.
    Medtronic
    Sanofi-Aventis SA
By Region
    North America
        United States
        Canada
    Europe
        Germany
        France
        UK
        Italy
        Russia
        Nordic Countries
        Rest of Europe
    Asia-Pacific
        China
        Japan
        South Korea
        Southeast Asia
        India
        Australia
        Rest of Asia
    Latin America
        Mexico
        Brazil
        Rest of Latin America
    Middle East & Africa
        Turkey
        Saudi Arabia
        UAE
        Rest of MEA
                           

                       
                        

                         
1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Prostate-specific Antigen (PSA) Testing Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 CLIA Method
        1.2.3 ELISA Method
    1.3 Market by Application
        1.3.1 Global Prostate-specific Antigen (PSA) Testing Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Screening
        1.3.3 Post-treatment Monitoring
        1.3.4 Other
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Prostate-specific Antigen (PSA) Testing Market Perspective (2017-2028)
    2.2 Prostate-specific Antigen (PSA) Testing Growth Trends by Region
        2.2.1 Prostate-specific Antigen (PSA) Testing Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Prostate-specific Antigen (PSA) Testing Historic Market Size by Region (2017-2022)
        2.2.3 Prostate-specific Antigen (PSA) Testing Forecasted Market Size by Region (2023-2028)
    2.3 Prostate-specific Antigen (PSA) Testing Market Dynamics
        2.3.1 Prostate-specific Antigen (PSA) Testing Industry Trends
        2.3.2 Prostate-specific Antigen (PSA) Testing Market Drivers
        2.3.3 Prostate-specific Antigen (PSA) Testing Market Challenges
        2.3.4 Prostate-specific Antigen (PSA) Testing Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Prostate-specific Antigen (PSA) Testing Players by Revenue
        3.1.1 Global Top Prostate-specific Antigen (PSA) Testing Players by Revenue (2017-2022)
        3.1.2 Global Prostate-specific Antigen (PSA) Testing Revenue Market Share by Players (2017-2022)
    3.2 Global Prostate-specific Antigen (PSA) Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Prostate-specific Antigen (PSA) Testing Revenue
    3.4 Global Prostate-specific Antigen (PSA) Testing Market Concentration Ratio
        3.4.1 Global Prostate-specific Antigen (PSA) Testing Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Prostate-specific Antigen (PSA) Testing Revenue in 2021
    3.5 Prostate-specific Antigen (PSA) Testing Key Players Head office and Area Served
    3.6 Key Players Prostate-specific Antigen (PSA) Testing Product Solution and Service
    3.7 Date of Enter into Prostate-specific Antigen (PSA) Testing Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Prostate-specific Antigen (PSA) Testing Breakdown Data by Type
    4.1 Global Prostate-specific Antigen (PSA) Testing Historic Market Size by Type (2017-2022)
    4.2 Global Prostate-specific Antigen (PSA) Testing Forecasted Market Size by Type (2023-2028)
5 Prostate-specific Antigen (PSA) Testing Breakdown Data by Application
    5.1 Global Prostate-specific Antigen (PSA) Testing Historic Market Size by Application (2017-2022)
    5.2 Global Prostate-specific Antigen (PSA) Testing Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Prostate-specific Antigen (PSA) Testing Market Size (2017-2028)
    6.2 North America Prostate-specific Antigen (PSA) Testing Market Size by Type
        6.2.1 North America Prostate-specific Antigen (PSA) Testing Market Size by Type (2017-2022)
        6.2.2 North America Prostate-specific Antigen (PSA) Testing Market Size by Type (2023-2028)
        6.2.3 North America Prostate-specific Antigen (PSA) Testing Market Share by Type (2017-2028)
    6.3 North America Prostate-specific Antigen (PSA) Testing Market Size by Application
        6.3.1 North America Prostate-specific Antigen (PSA) Testing Market Size by Application (2017-2022)
        6.3.2 North America Prostate-specific Antigen (PSA) Testing Market Size by Application (2023-2028)
        6.3.3 North America Prostate-specific Antigen (PSA) Testing Market Share by Application (2017-2028)
    6.4 North America Prostate-specific Antigen (PSA) Testing Market Size by Country
        6.4.1 North America Prostate-specific Antigen (PSA) Testing Market Size by Country (2017-2022)
        6.4.2 North America Prostate-specific Antigen (PSA) Testing Market Size by Country (2023-2028)
        6.4.3 U.S.
        6.4.4 Canada
7 Europe
    7.1 Europe Prostate-specific Antigen (PSA) Testing Market Size (2017-2028)
    7.2 Europe Prostate-specific Antigen (PSA) Testing Market Size by Type
        7.2.1 Europe Prostate-specific Antigen (PSA) Testing Market Size by Type (2017-2022)
        7.2.2 Europe Prostate-specific Antigen (PSA) Testing Market Size by Type (2023-2028)
        7.2.3 Europe Prostate-specific Antigen (PSA) Testing Market Share by Type (2017-2028)
    7.3 Europe Prostate-specific Antigen (PSA) Testing Market Size by Application
        7.3.1 Europe Prostate-specific Antigen (PSA) Testing Market Size by Application (2017-2022)
        7.3.2 Europe Prostate-specific Antigen (PSA) Testing Market Size by Application (2023-2028)
        7.3.3 Europe Prostate-specific Antigen (PSA) Testing Market Share by Application (2017-2028)
    7.4 Europe Prostate-specific Antigen (PSA) Testing Market Size by Country
        7.4.1 Europe Prostate-specific Antigen (PSA) Testing Market Size by Country (2017-2022)
        7.4.2 Europe Prostate-specific Antigen (PSA) Testing Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Prostate-specific Antigen (PSA) Testing Market Size (2017-2028)
    8.2 Asia-Pacific Prostate-specific Antigen (PSA) Testing Market Size by Type
        8.2.1 Asia-Pacific Prostate-specific Antigen (PSA) Testing Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific Prostate-specific Antigen (PSA) Testing Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific Prostate-specific Antigen (PSA) Testing Market Share by Type (2017-2028)
    8.3 Asia-Pacific Prostate-specific Antigen (PSA) Testing Market Size by Application
        8.3.1 Asia-Pacific Prostate-specific Antigen (PSA) Testing Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific Prostate-specific Antigen (PSA) Testing Market Size by Application (2023-2028)
        8.3.3 Asia-Pacific Prostate-specific Antigen (PSA) Testing Market Share by Application (2017-2028)
    8.4 Asia-Pacific Prostate-specific Antigen (PSA) Testing Market Size by Region
        8.4.1 Asia-Pacific Prostate-specific Antigen (PSA) Testing Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific Prostate-specific Antigen (PSA) Testing Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America Prostate-specific Antigen (PSA) Testing Market Size (2017-2028)
    9.2 Latin America Prostate-specific Antigen (PSA) Testing Market Size by Type
        9.2.1 Latin America Prostate-specific Antigen (PSA) Testing Market Size by Type (2017-2022)
        9.2.2 Latin America Prostate-specific Antigen (PSA) Testing Market Size by Type (2023-2028)
        9.2.3 Latin America Prostate-specific Antigen (PSA) Testing Market Share by Type (2017-2028)
    9.3 Latin America Prostate-specific Antigen (PSA) Testing Market Size by Application
        9.3.1 Latin America Prostate-specific Antigen (PSA) Testing Market Size by Application (2017-2022)
        9.3.2 Latin America Prostate-specific Antigen (PSA) Testing Market Size by Application (2023-2028)
        9.3.3 Latin America Prostate-specific Antigen (PSA) Testing Market Share by Application (2017-2028)
    9.4 Latin America Prostate-specific Antigen (PSA) Testing Market Size by Country
        9.4.1 Latin America Prostate-specific Antigen (PSA) Testing Market Size by Country (2017-2022)
        9.4.2 Latin America Prostate-specific Antigen (PSA) Testing Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Prostate-specific Antigen (PSA) Testing Market Size (2017-2028)
    10.2 Middle East & Africa Prostate-specific Antigen (PSA) Testing Market Size by Type
        10.2.1 Middle East & Africa Prostate-specific Antigen (PSA) Testing Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa Prostate-specific Antigen (PSA) Testing Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa Prostate-specific Antigen (PSA) Testing Market Share by Type (2017-2028)
    10.3 Middle East & Africa Prostate-specific Antigen (PSA) Testing Market Size by Application
        10.3.1 Middle East & Africa Prostate-specific Antigen (PSA) Testing Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa Prostate-specific Antigen (PSA) Testing Market Size by Application (2023-2028)
        10.3.3 Middle East & Africa Prostate-specific Antigen (PSA) Testing Market Share by Application (2017-2028)
    10.4 Middle East & Africa Prostate-specific Antigen (PSA) Testing Market Size by Country
        10.4.1 Middle East & Africa Prostate-specific Antigen (PSA) Testing Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa Prostate-specific Antigen (PSA) Testing Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 Abbott
        11.1.1 Abbott Company Details
        11.1.2 Abbott Business Overview
        11.1.3 Abbott Prostate-specific Antigen (PSA) Testing Introduction
        11.1.4 Abbott Revenue in Prostate-specific Antigen (PSA) Testing Business (2017-2022)
        11.1.5 Abbott Recent Developments
    11.2 Boston Scientific Corporation
        11.2.1 Boston Scientific Corporation Company Details
        11.2.2 Boston Scientific Corporation Business Overview
        11.2.3 Boston Scientific Corporation Prostate-specific Antigen (PSA) Testing Introduction
        11.2.4 Boston Scientific Corporation Revenue in Prostate-specific Antigen (PSA) Testing Business (2017-2022)
        11.2.5 Boston Scientific Corporation Recent Developments
    11.3 Bayer AG
        11.3.1 Bayer AG Company Details
        11.3.2 Bayer AG Business Overview
        11.3.3 Bayer AG Prostate-specific Antigen (PSA) Testing Introduction
        11.3.4 Bayer AG Revenue in Prostate-specific Antigen (PSA) Testing Business (2017-2022)
        11.3.5 Bayer AG Recent Developments
    11.4 Siemens Healthcare
        11.4.1 Siemens Healthcare Company Details
        11.4.2 Siemens Healthcare Business Overview
        11.4.3 Siemens Healthcare Prostate-specific Antigen (PSA) Testing Introduction
        11.4.4 Siemens Healthcare Revenue in Prostate-specific Antigen (PSA) Testing Business (2017-2022)
        11.4.5 Siemens Healthcare Recent Developments
    11.5 DiaSorin
        11.5.1 DiaSorin Company Details
        11.5.2 DiaSorin Business Overview
        11.5.3 DiaSorin Prostate-specific Antigen (PSA) Testing Introduction
        11.5.4 DiaSorin Revenue in Prostate-specific Antigen (PSA) Testing Business (2017-2022)
        11.5.5 DiaSorin Recent Developments
    11.6 Roche
        11.6.1 Roche Company Details
        11.6.2 Roche Business Overview
        11.6.3 Roche Prostate-specific Antigen (PSA) Testing Introduction
        11.6.4 Roche Revenue in Prostate-specific Antigen (PSA) Testing Business (2017-2022)
        11.6.5 Roche Recent Developments
    11.7 Beckman Coulter
        11.7.1 Beckman Coulter Company Details
        11.7.2 Beckman Coulter Business Overview
        11.7.3 Beckman Coulter Prostate-specific Antigen (PSA) Testing Introduction
        11.7.4 Beckman Coulter Revenue in Prostate-specific Antigen (PSA) Testing Business (2017-2022)
        11.7.5 Beckman Coulter Recent Developments
    11.8 PerkinElmer
        11.8.1 PerkinElmer Company Details
        11.8.2 PerkinElmer Business Overview
        11.8.3 PerkinElmer Prostate-specific Antigen (PSA) Testing Introduction
        11.8.4 PerkinElmer Revenue in Prostate-specific Antigen (PSA) Testing Business (2017-2022)
        11.8.5 PerkinElmer Recent Developments
    11.9 Tosoh
        11.9.1 Tosoh Company Details
        11.9.2 Tosoh Business Overview
        11.9.3 Tosoh Prostate-specific Antigen (PSA) Testing Introduction
        11.9.4 Tosoh Revenue in Prostate-specific Antigen (PSA) Testing Business (2017-2022)
        11.9.5 Tosoh Recent Developments
    11.10 Ortho Clinical
        11.10.1 Ortho Clinical Company Details
        11.10.2 Ortho Clinical Business Overview
        11.10.3 Ortho Clinical Prostate-specific Antigen (PSA) Testing Introduction
        11.10.4 Ortho Clinical Revenue in Prostate-specific Antigen (PSA) Testing Business (2017-2022)
        11.10.5 Ortho Clinical Recent Developments
    11.11 Fujirebio
        11.11.1 Fujirebio Company Details
        11.11.2 Fujirebio Business Overview
        11.11.3 Fujirebio Prostate-specific Antigen (PSA) Testing Introduction
        11.11.4 Fujirebio Revenue in Prostate-specific Antigen (PSA) Testing Business (2017-2022)
        11.11.5 Fujirebio Recent Developments
    11.12 Mediwatch
        11.12.1 Mediwatch Company Details
        11.12.2 Mediwatch Business Overview
        11.12.3 Mediwatch Prostate-specific Antigen (PSA) Testing Introduction
        11.12.4 Mediwatch Revenue in Prostate-specific Antigen (PSA) Testing Business (2017-2022)
        11.12.5 Mediwatch Recent Developments
    11.13 BodiTech
        11.13.1 BodiTech Company Details
        11.13.2 BodiTech Business Overview
        11.13.3 BodiTech Prostate-specific Antigen (PSA) Testing Introduction
        11.13.4 BodiTech Revenue in Prostate-specific Antigen (PSA) Testing Business (2017-2022)
        11.13.5 BodiTech Recent Developments
    11.14 Bristol-Myers Squibb Company
        11.14.1 Bristol-Myers Squibb Company Company Details
        11.14.2 Bristol-Myers Squibb Company Business Overview
        11.14.3 Bristol-Myers Squibb Company Prostate-specific Antigen (PSA) Testing Introduction
        11.14.4 Bristol-Myers Squibb Company Revenue in Prostate-specific Antigen (PSA) Testing Business (2017-2022)
        11.14.5 Bristol-Myers Squibb Company Recent Developments
    11.15 GE Healthcare
        11.15.1 GE Healthcare Company Details
        11.15.2 GE Healthcare Business Overview
        11.15.3 GE Healthcare Prostate-specific Antigen (PSA) Testing Introduction
        11.15.4 GE Healthcare Revenue in Prostate-specific Antigen (PSA) Testing Business (2017-2022)
        11.15.5 GE Healthcare Recent Developments
    11.16 Endocare
        11.16.1 Endocare Company Details
        11.16.2 Endocare Business Overview
        11.16.3 Endocare Prostate-specific Antigen (PSA) Testing Introduction
        11.16.4 Endocare Revenue in Prostate-specific Antigen (PSA) Testing Business (2017-2022)
        11.16.5 Endocare Recent Developments
    11.17 Merck?Co.
        11.17.1 Merck?Co. Company Details
        11.17.2 Merck?Co. Business Overview
        11.17.3 Merck?Co. Prostate-specific Antigen (PSA) Testing Introduction
        11.17.4 Merck?Co. Revenue in Prostate-specific Antigen (PSA) Testing Business (2017-2022)
        11.17.5 Merck?Co. Recent Developments
    11.18 Medtronic
        11.18.1 Medtronic Company Details
        11.18.2 Medtronic Business Overview
        11.18.3 Medtronic Prostate-specific Antigen (PSA) Testing Introduction
        11.18.4 Medtronic Revenue in Prostate-specific Antigen (PSA) Testing Business (2017-2022)
        11.18.5 Medtronic Recent Developments
    11.19 Sanofi-Aventis SA
        11.19.1 Sanofi-Aventis SA Company Details
        11.19.2 Sanofi-Aventis SA Business Overview
        11.19.3 Sanofi-Aventis SA Prostate-specific Antigen (PSA) Testing Introduction
        11.19.4 Sanofi-Aventis SA Revenue in Prostate-specific Antigen (PSA) Testing Business (2017-2022)
        11.19.5 Sanofi-Aventis SA Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer
Read More 
                

                 
List of Tables
    Table 1. Global Prostate-specific Antigen (PSA) Testing Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of CLIA Method
    Table 3. Key Players of ELISA Method
    Table 4. Global Prostate-specific Antigen (PSA) Testing Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 5. Global Prostate-specific Antigen (PSA) Testing Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global Prostate-specific Antigen (PSA) Testing Market Size by Region (2017-2022) & (US$ Million)
    Table 7. Global Prostate-specific Antigen (PSA) Testing Market Share by Region (2017-2022)
    Table 8. Global Prostate-specific Antigen (PSA) Testing Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 9. Global Prostate-specific Antigen (PSA) Testing Market Share by Region (2023-2028)
    Table 10. Prostate-specific Antigen (PSA) Testing Market Trends
    Table 11. Prostate-specific Antigen (PSA) Testing Market Drivers
    Table 12. Prostate-specific Antigen (PSA) Testing Market Challenges
    Table 13. Prostate-specific Antigen (PSA) Testing Market Restraints
    Table 14. Global Prostate-specific Antigen (PSA) Testing Revenue by Players (2017-2022) & (US$ Million)
    Table 15. Global Prostate-specific Antigen (PSA) Testing Revenue Share by Players (2017-2022)
    Table 16. Global Top Prostate-specific Antigen (PSA) Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostate-specific Antigen (PSA) Testing as of 2021)
    Table 17. Ranking of Global Top Prostate-specific Antigen (PSA) Testing Companies by Revenue (US$ Million) in 2021
    Table 18. Global 5 Largest Players Market Share by Prostate-specific Antigen (PSA) Testing Revenue (CR5 and HHI) & (2017-2022)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Prostate-specific Antigen (PSA) Testing Product Solution and Service
    Table 21. Date of Enter into Prostate-specific Antigen (PSA) Testing Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Prostate-specific Antigen (PSA) Testing Market Size by Type (2017-2022) & (US$ Million)
    Table 24. Global Prostate-specific Antigen (PSA) Testing Revenue Market Share by Type (2017-2022)
    Table 25. Global Prostate-specific Antigen (PSA) Testing Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 26. Global Prostate-specific Antigen (PSA) Testing Revenue Market Share by Type (2023-2028)
    Table 27. Global Prostate-specific Antigen (PSA) Testing Market Size by Application (2017-2022) & (US$ Million)
    Table 28. Global Prostate-specific Antigen (PSA) Testing Revenue Share by Application (2017-2022)
    Table 29. Global Prostate-specific Antigen (PSA) Testing Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 30. Global Prostate-specific Antigen (PSA) Testing Revenue Share by Application (2023-2028)
    Table 31. North America Prostate-specific Antigen (PSA) Testing Market Size by Type (2017-2022) & (US$ Million)
    Table 32. North America Prostate-specific Antigen (PSA) Testing Market Size by Type (2023-2028) & (US$ Million)
    Table 33. North America Prostate-specific Antigen (PSA) Testing Market Size by Application (2017-2022) & (US$ Million)
    Table 34. North America Prostate-specific Antigen (PSA) Testing Market Size by Application (2023-2028) & (US$ Million)
    Table 35. North America Prostate-specific Antigen (PSA) Testing Market Size by Country (2017-2022) & (US$ Million)
    Table 36. North America Prostate-specific Antigen (PSA) Testing Market Size by Country (2023-2028) & (US$ Million)
    Table 37. Europe Prostate-specific Antigen (PSA) Testing Market Size by Type (2017-2022) & (US$ Million)
    Table 38. Europe Prostate-specific Antigen (PSA) Testing Market Size by Type (2023-2028) & (US$ Million)
    Table 39. Europe Prostate-specific Antigen (PSA) Testing Market Size by Application (2017-2022) & (US$ Million)
    Table 40. Europe Prostate-specific Antigen (PSA) Testing Market Size by Application (2023-2028) & (US$ Million)
    Table 41. Europe Prostate-specific Antigen (PSA) Testing Market Size by Country (2017-2022) & (US$ Million)
    Table 42. Europe Prostate-specific Antigen (PSA) Testing Market Size by Country (2023-2028) & (US$ Million)
    Table 43. Asia Pacific Prostate-specific Antigen (PSA) Testing Market Size by Type (2017-2022) & (US$ Million)
    Table 44. Asia Pacific Prostate-specific Antigen (PSA) Testing Market Size by Type (2023-2028) & (US$ Million)
    Table 45. Asia Pacific Prostate-specific Antigen (PSA) Testing Market Size by Application (2017-2022) & (US$ Million)
    Table 46. Asia Pacific Prostate-specific Antigen (PSA) Testing Market Size by Application (2023-2028) & (US$ Million)
    Table 47. Asia Pacific Prostate-specific Antigen (PSA) Testing Market Size by Region (2017-2022) & (US$ Million)
    Table 48. Asia Pacific Prostate-specific Antigen (PSA) Testing Market Size by Region (2023-2028) & (US$ Million)
    Table 49. Latin America Prostate-specific Antigen (PSA) Testing Market Size by Type (2017-2022) & (US$ Million)
    Table 50. Latin America Prostate-specific Antigen (PSA) Testing Market Size by Type (2023-2028) & (US$ Million)
    Table 51. Latin America Prostate-specific Antigen (PSA) Testing Market Size by Application (2017-2022) & (US$ Million)
    Table 52. Latin America Prostate-specific Antigen (PSA) Testing Market Size by Application (2023-2028) & (US$ Million)
    Table 53. Latin America Prostate-specific Antigen (PSA) Testing Market Size by Country (2017-2022) & (US$ Million)
    Table 54. Latin America Prostate-specific Antigen (PSA) Testing Market Size by Country (2023-2028) & (US$ Million)
    Table 55. Middle East and Africa Prostate-specific Antigen (PSA) Testing Market Size by Type (2017-2022) & (US$ Million)
    Table 56. Middle East and Africa Prostate-specific Antigen (PSA) Testing Market Size by Type (2023-2028) & (US$ Million)
    Table 57. Middle East and Africa Prostate-specific Antigen (PSA) Testing Market Size by Application (2017-2022) & (US$ Million)
    Table 58. Middle East and Africa Prostate-specific Antigen (PSA) Testing Market Size by Application (2023-2028) & (US$ Million)
    Table 59. Middle East and Africa Prostate-specific Antigen (PSA) Testing Market Size by Country (2017-2022) & (US$ Million)
    Table 60. Middle East and Africa Prostate-specific Antigen (PSA) Testing Market Size by Country (2023-2028) & (US$ Million)
    Table 61. Abbott Company Details
    Table 62. Abbott Business Overview
    Table 63. Abbott Prostate-specific Antigen (PSA) Testing Product
    Table 64. Abbott Revenue in Prostate-specific Antigen (PSA) Testing Business (2017-2022) & (US$ Million)
    Table 65. Abbott Recent Developments
    Table 66. Boston Scientific Corporation Company Details
    Table 67. Boston Scientific Corporation Business Overview
    Table 68. Boston Scientific Corporation Prostate-specific Antigen (PSA) Testing Product
    Table 69. Boston Scientific Corporation Revenue in Prostate-specific Antigen (PSA) Testing Business (2017-2022) & (US$ Million)
    Table 70. Boston Scientific Corporation Recent Developments
    Table 71. Bayer AG Company Details
    Table 72. Bayer AG Business Overview
    Table 73. Bayer AG Prostate-specific Antigen (PSA) Testing Product
    Table 74. Bayer AG Revenue in Prostate-specific Antigen (PSA) Testing Business (2017-2022) & (US$ Million)
    Table 75. Bayer AG Recent Developments
    Table 76. Siemens Healthcare Company Details
    Table 77. Siemens Healthcare Business Overview
    Table 78. Siemens Healthcare Prostate-specific Antigen (PSA) Testing Product
    Table 79. Siemens Healthcare Revenue in Prostate-specific Antigen (PSA) Testing Business (2017-2022) & (US$ Million)
    Table 80. Siemens Healthcare Recent Developments
    Table 81. DiaSorin Company Details
    Table 82. DiaSorin Business Overview
    Table 83. DiaSorin Prostate-specific Antigen (PSA) Testing Product
    Table 84. DiaSorin Revenue in Prostate-specific Antigen (PSA) Testing Business (2017-2022) & (US$ Million)
    Table 85. DiaSorin Recent Developments
    Table 86. Roche Company Details
    Table 87. Roche Business Overview
    Table 88. Roche Prostate-specific Antigen (PSA) Testing Product
    Table 89. Roche Revenue in Prostate-specific Antigen (PSA) Testing Business (2017-2022) & (US$ Million)
    Table 90. Roche Recent Developments
    Table 91. Beckman Coulter Company Details
    Table 92. Beckman Coulter Business Overview
    Table 93. Beckman Coulter Prostate-specific Antigen (PSA) Testing Product
    Table 94. Beckman Coulter Revenue in Prostate-specific Antigen (PSA) Testing Business (2017-2022) & (US$ Million)
    Table 95. Beckman Coulter Recent Developments
    Table 96. PerkinElmer Company Details
    Table 97. PerkinElmer Business Overview
    Table 98. PerkinElmer Prostate-specific Antigen (PSA) Testing Product
    Table 99. PerkinElmer Revenue in Prostate-specific Antigen (PSA) Testing Business (2017-2022) & (US$ Million)
    Table 100. PerkinElmer Recent Developments
    Table 101. Tosoh Company Details
    Table 102. Tosoh Business Overview
    Table 103. Tosoh Prostate-specific Antigen (PSA) Testing Product
    Table 104. Tosoh Revenue in Prostate-specific Antigen (PSA) Testing Business (2017-2022) & (US$ Million)
    Table 105. Tosoh Recent Developments
    Table 106. Ortho Clinical Company Details
    Table 107. Ortho Clinical Business Overview
    Table 108. Ortho Clinical Prostate-specific Antigen (PSA) Testing Product
    Table 109. Ortho Clinical Revenue in Prostate-specific Antigen (PSA) Testing Business (2017-2022) & (US$ Million)
    Table 110. Ortho Clinical Recent Developments
    Table 111. Fujirebio Company Details
    Table 112. Fujirebio Business Overview
    Table 113. Fujirebio Prostate-specific Antigen (PSA) Testing Product
    Table 114. Fujirebio Revenue in Prostate-specific Antigen (PSA) Testing Business (2017-2022) & (US$ Million)
    Table 115. Fujirebio Recent Developments
    Table 116. Mediwatch Company Details
    Table 117. Mediwatch Business Overview
    Table 118. Mediwatch Prostate-specific Antigen (PSA) Testing Product
    Table 119. Mediwatch Revenue in Prostate-specific Antigen (PSA) Testing Business (2017-2022) & (US$ Million)
    Table 120. Mediwatch Recent Developments
    Table 121. BodiTech Company Details
    Table 122. BodiTech Business Overview
    Table 123. BodiTech Prostate-specific Antigen (PSA) Testing Product
    Table 124. BodiTech Revenue in Prostate-specific Antigen (PSA) Testing Business (2017-2022) & (US$ Million)
    Table 125. BodiTech Recent Developments
    Table 126. Bristol-Myers Squibb Company Company Details
    Table 127. Bristol-Myers Squibb Company Business Overview
    Table 128. Bristol-Myers Squibb Company Prostate-specific Antigen (PSA) Testing Product
    Table 129. Bristol-Myers Squibb Company Revenue in Prostate-specific Antigen (PSA) Testing Business (2017-2022) & (US$ Million)
    Table 130. Bristol-Myers Squibb Company Recent Developments
    Table 131. GE Healthcare Company Details
    Table 132. GE Healthcare Business Overview
    Table 133. GE Healthcare Prostate-specific Antigen (PSA) Testing Product
    Table 134. GE Healthcare Revenue in Prostate-specific Antigen (PSA) Testing Business (2017-2022) & (US$ Million)
    Table 135. GE Healthcare Recent Developments
    Table 136. Endocare Company Details
    Table 137. Endocare Business Overview
    Table 138. Endocare Prostate-specific Antigen (PSA) Testing Product
    Table 139. Endocare Revenue in Prostate-specific Antigen (PSA) Testing Business (2017-2022) & (US$ Million)
    Table 140. Endocare Recent Developments
    Table 141. Merck?Co. Company Details
    Table 142. Merck?Co. Business Overview
    Table 143. Merck?Co. Prostate-specific Antigen (PSA) Testing Product
    Table 144. Merck?Co. Revenue in Prostate-specific Antigen (PSA) Testing Business (2017-2022) & (US$ Million)
    Table 145. Merck?Co. Recent Developments
    Table 146. Medtronic Company Details
    Table 147. Medtronic Business Overview
    Table 148. Medtronic Prostate-specific Antigen (PSA) Testing Product
    Table 149. Medtronic Revenue in Prostate-specific Antigen (PSA) Testing Business (2017-2022) & (US$ Million)
    Table 150. Medtronic Recent Developments
    Table 151. Sanofi-Aventis SA Company Details
    Table 152. Sanofi-Aventis SA Business Overview
    Table 153. Sanofi-Aventis SA Prostate-specific Antigen (PSA) Testing Product
    Table 154. Sanofi-Aventis SA Revenue in Prostate-specific Antigen (PSA) Testing Business (2017-2022) & (US$ Million)
    Table 155. Sanofi-Aventis SA Recent Developments
    Table 156. Research Programs/Design for This Report
    Table 157. Key Data Information from Secondary Sources
    Table 158. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Prostate-specific Antigen (PSA) Testing Market Share by Type: 2021 VS 2028
    Figure 2. CLIA Method Features
    Figure 3. ELISA Method Features
    Figure 4. Global Prostate-specific Antigen (PSA) Testing Market Share by Application: 2021 VS 2028
    Figure 5. Screening Case Studies
    Figure 6. Post-treatment Monitoring Case Studies
    Figure 7. Other Case Studies
    Figure 8. Prostate-specific Antigen (PSA) Testing Report Years Considered
    Figure 9. Global Prostate-specific Antigen (PSA) Testing Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 10. Global Prostate-specific Antigen (PSA) Testing Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 11. Global Prostate-specific Antigen (PSA) Testing Market Share by Region: 2021 VS 2028
    Figure 12. Global Prostate-specific Antigen (PSA) Testing Market Share by Players in 2021
    Figure 13. Global Top Prostate-specific Antigen (PSA) Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostate-specific Antigen (PSA) Testing as of 2021)
    Figure 14. The Top 10 and 5 Players Market Share by Prostate-specific Antigen (PSA) Testing Revenue in 2021
    Figure 15. North America Prostate-specific Antigen (PSA) Testing Market Size YoY (2017-2028) & (US$ Million)
    Figure 16. North America Prostate-specific Antigen (PSA) Testing Market Size Market Share by Type (2017-2028)
    Figure 17. North America Prostate-specific Antigen (PSA) Testing Market Size Market Share by Application (2017-2028)
    Figure 18. North America Prostate-specific Antigen (PSA) Testing Market Size Share by Country (2017-2028)
    Figure 19. United States Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Canada Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Europe Prostate-specific Antigen (PSA) Testing Market Size YoY (2017-2028) & (US$ Million)
    Figure 22. Europe Prostate-specific Antigen (PSA) Testing Market Size Market Share by Type (2017-2028)
    Figure 23. Europe Prostate-specific Antigen (PSA) Testing Market Size Market Share by Application (2017-2028)
    Figure 24. Europe Prostate-specific Antigen (PSA) Testing Market Size Share by Country (2017-2028)
    Figure 25. Germany Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. France Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. U.K. Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Italy Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Russia Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Nordic Countries Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Asia-Pacific Prostate-specific Antigen (PSA) Testing Market Size YoY (2017-2028) & (US$ Million)
    Figure 32. Asia Pacific Prostate-specific Antigen (PSA) Testing Market Size Market Share by Type (2017-2028)
    Figure 33. Asia Pacific Prostate-specific Antigen (PSA) Testing Market Size Market Share by Application (2017-2028)
    Figure 34. Asia Pacific Prostate-specific Antigen (PSA) Testing Market Size Share by Region (2017-2028)
    Figure 35. China Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Japan Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. South Korea Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Southeast Asia Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. India Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Australia Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
    Figure 41. Latin America Prostate-specific Antigen (PSA) Testing Market Size YoY (2017-2028) & (US$ Million)
    Figure 42. Latin America Prostate-specific Antigen (PSA) Testing Market Size Market Share by Type (2017-2028)
    Figure 43. Latin America Prostate-specific Antigen (PSA) Testing Market Size Market Share by Application (2017-2028)
    Figure 44. Latin America Prostate-specific Antigen (PSA) Testing Market Size Share by Country (2017-2028)
    Figure 45. Mexico Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 46. Brazil Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 47. Middle East & Africa Prostate-specific Antigen (PSA) Testing Market Size YoY (2017-2028) & (US$ Million)
    Figure 48. Middle East and Africa Prostate-specific Antigen (PSA) Testing Market Size Market Share by Type (2017-2028)
    Figure 49. Middle East and Africa Prostate-specific Antigen (PSA) Testing Market Size Market Share by Application (2017-2028)
    Figure 50. Middle East and Africa Prostate-specific Antigen (PSA) Testing Market Size Share by Country (2017-2028)
    Figure 51. Turkey Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 52. Saudi Arabia Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 53. UAE Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 54. Abbott Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2017-2022)
    Figure 55. Boston Scientific Corporation Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2017-2022)
    Figure 56. Bayer AG Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2017-2022)
    Figure 57. Siemens Healthcare Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2017-2022)
    Figure 58. DiaSorin Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2017-2022)
    Figure 59. Roche Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2017-2022)
    Figure 60. Beckman Coulter Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2017-2022)
    Figure 61. PerkinElmer Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2017-2022)
    Figure 62. Tosoh Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2017-2022)
    Figure 63. Ortho Clinical Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2017-2022)
    Figure 64. Fujirebio Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2017-2022)
    Figure 65. Mediwatch Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2017-2022)
    Figure 66. BodiTech Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2017-2022)
    Figure 67. Bristol-Myers Squibb Company Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2017-2022)
    Figure 68. GE Healthcare Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2017-2022)
    Figure 69. Endocare Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2017-2022)
    Figure 70. Merck?Co. Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2017-2022)
    Figure 71. Medtronic Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2017-2022)
    Figure 72. Sanofi-Aventis SA Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2017-2022)
    Figure 73. Bottom-up and Top-down Approaches for This Report
    Figure 74. Data Triangulation
    Figure 75. Key Executives Interviewed

Purchase Report

Single User 3480
Multi User 5250
Corporate User 6960
Buy

Speak To Analyst

Purchase Report

Customize the purchase as per your specific research needs:

  • 20% additional customization
  • Request for country level reports
  • Request for historical statistics
  • Additional company profile on request

Why Choose Our Report?

24/5 Research support

Get your queries resolved from an industry expert

Custom research service

Design an exclusive study to serve your research needs.

Information security

Your personal and confidential information is safe and secure.

Related Reports

Global Opioid Induced Constipation Treatment Market Insights, Forecast to 2028
  • Report ID:245856
  • Industry Name: Medical Care
  • Publishing Date: Jun-22
  • No. of Pages: 117
  • 3480

Tissue Expander and Implants Used in Breast Reconstruction Market Research: Global Status...
  • Report ID:91838
  • Industry Name: Medical Care
  • Publishing Date: Jun-22
  • No. of Pages: 117
  • 2280

Global Post-Traumatic Stress Disorder Treatment Market Insights, Forecast to 2028
  • Report ID:246816
  • Industry Name: Medical Care
  • Publishing Date: Jun-22
  • No. of Pages: 117
  • 3480

Global Musculoskeletal System Disorder Market 2021 by Company, Regions, Type and Applicat...
  • Report ID:96751
  • Industry Name: Medical Care
  • Publishing Date: Jun-22
  • No. of Pages: 117
  • 3480

Global Head And Neck Squamous Cell Carcinoma Treatment Market Insights, Forecast to 2028
  • Report ID:248539
  • Industry Name: Medical Care
  • Publishing Date: Jun-22
  • No. of Pages: 117
  • 3480

clock

+1  347 708 0418

clocksales@acorinsights.com

trusted-site ssl paypal

COPYRIGHT © 2021 Acor Insights | All Rights Reserved.